Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.067 USD | +2.34% | -2.49% | -57.81% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wee Kiat Tan
CEO | Chief Executive Officer | 36 | 31/01/19 |
Yvonne Goh
DFI | Director of Finance/CFO | 35 | 29/02/20 |
Jieming Zeng
CTO | Chief Tech/Sci/R&D Officer | 51 | 31/07/19 |
Tien Wee Luk
CTO | Chief Tech/Sci/R&D Officer | 39 | 31/12/20 |
Yoong Ying Tan
IRC | Investor Relations Contact | 35 | 31/05/18 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chee Kong Choo
FOU | Founder | 65 | 08/03/18 |
Tao Wu
BRD | Director/Board Member | 59 | 17/04/23 |
Kei Wei Leong
BRD | Director/Board Member | 49 | 17/04/23 |
Wee Kiat Tan
CEO | Chief Executive Officer | 36 | 31/01/19 |
Tien Wee Luk
CTO | Chief Tech/Sci/R&D Officer | 39 | 31/12/20 |
Jieming Zeng
CTO | Chief Tech/Sci/R&D Officer | 51 | 31/07/19 |
Yuin Han Loh
BRD | Director/Board Member | 47 | 17/04/23 |
Chak Hua Yew
BRD | Director/Board Member | 39 | 17/04/23 |
Keng Kiat Toh
BRD | Director/Board Member | 83 | 17/04/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,540,000 | 3,380,798 ( 29.30 %) | 0 | 29.30 % |
Company contact information
CytoMed Therapeutics Ltd.
1 Commonwealth Lane No. 08-22, One Commonwealth
149544, Singapore
+65 6250 7738
http://www.cytomed.sgSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.81% | 23.86M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- GDTC Stock
- Company CytoMed Therapeutics Limited